510(k) Report

510(k) · Cleared

Cleared

ALTMS Magnetic Stimulation Therapy System

K202537510(k) TraditionalCleared Nov 26, 2021451-day reviewClass II21 CFR 882.5805

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Remed Co., Ltd. · OBP Transcranial Magnetic Stimulator

Cleared on Nov 26, 2021 as substantially equivalent to K143531 (Magstim Company Limited, 2015) after a 451-day review. Its family tree reaches back 5 generations to 2008. 2 later devices descend from it.

Decided
Nov 26, 2021
Review
451 days
Class
Class II
Product code
OBP
Recalls
None
Predicates
1

Its longest line of descent runs back 5 generations to DEN070003 (2008). 2 later devices descend from it, 1 citing it directly.

  1. Root · 5 generations backDEN070003 Neurostar TMS SystemNeuronetics · 2008
  2. 4 generations backK083538 Neurostar TMS Therapy System, Model 1.1Neuronetics · 2008 · Recalled
  3. 3 generations backK130233 Neurostar TMS Therapy SystemNeuronetics · 2013
  4. 2 generations backK133408 Neurostar TMS Therapy SystemNeuronetics · 2014
  5. 1 generation backK143531 Rapid Therapy SystemMagstim Company Limited · 2015 · Recalled
  6. This deviceK202537 ALTMS Magnetic Stimulation Therapy SystemRemed Co., Ltd. · 2021
  7. Descendant · cites it directly · 1 of its ownK220625 ALTMS Magnetic Stimulation Therapy System, Blossom TMS Therapy SystemRemed Co., Ltd. · 2022
  8. Descendant · 2 generations on · 0 of its ownK251653 SPRY TMS Therapy System (0550)Soterix Medical, Inc. · 2026

Most influential descendants

Showing 2 of 2 · See all
  • K220625ALTMS Magnetic Stimulation Therapy System, Blossom TMS Therapy SystemRemed Co., Ltd. · 2022 · cites it directly1descendant
  • K251653SPRY TMS Therapy System (0550)Soterix Medical, Inc. · 2026 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−5DEN070003Neurostar TMS SystemNeuronetics2008—
−4K083538Neurostar TMS Therapy System, Model 1.1Neuronetics20081
−3K130233Neurostar TMS Therapy SystemNeuronetics2013—
−2K133408Neurostar TMS Therapy SystemNeuronetics2014—
−1K143531Rapid Therapy SystemMagstim Company Limited20153
0 (this device)K202537ALTMS Magnetic Stimulation Therapy SystemRemed Co., Ltd.2021—
+1K220625ALTMS Magnetic Stimulation Therapy System, Blossom TMS Therapy SystemRemed Co., Ltd.2022—
+2K251653SPRY TMS Therapy System (0550)Soterix Medical, Inc.2026—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202210
202610
FIG. 1 — Lineage of K202537, 2008–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in OBP? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new OBP device

  1. #1 K251119 MagVenture TMS Therapy Systemscore 21.8 · 11 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K143531Rapid Therapy System
Summary page 4
…Panel: Neurology • Regulation Number: 21 CFR 882.5805 • Regulatory Class: Class II • Product Code: OBP III. PREDICATE DEVICE Rapid2 Therapy System (K143531, Manufacturer: Magstim Company Limited) The predicate device has not been subject to a design-related recall. IV. DEV…
Magstim Company Limited20153

Also cleared against K143531: 6 other devices →

What descends from it? (2)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K220625ALTMS Magnetic Stimulation Therapy System, Blossom TMS Therapy SystemRemed Co., Ltd.20221

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 13 years and passes through 3 companies; a new generation was cleared every 1.1 years on median.
  • 2 of the 5 ancestors have a recall of any class.
  • Of its descendants, K220625 (Remed Co., Ltd., 2022) has gone furthest, with 1 descendant of its own.
  • 6 other devices also cite its predicate K143531.

How does its category compare?

All OBP devices

OBP Transcranial Magnetic Stimulator: FDA decisions, review times, recalls and adverse event reports over 20 years. 2021, this device’s year, is highlighted.

FDA decisions per year · OBP

12in 2025

2008: 22013: 22014: 12015: 22016: 32017: 82018: 42019: 32020: 12021: 52022: 62023: 72024: 52025: 122026 (partial year): 8
2007high 12 (2025) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · OBP

125in 2025

2016: 101 days median2017: 73 days median2018: 144 days median2019: 156 days median2021: 132 days median2022: 168 days median2023: 119 days median2024: 266 days median2025: 125 days median2026 (partial year): 176 days median
2007high 266 (2024) · low 73 (2017)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · OBP

1in 2018

2009: 12018: 12026 (partial year): 1
2007high 1 (2009) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · OBP

81in 2025

2009: 32011: 52012: 32013: 12015: 32016: 62017: 32018: 62019: 122020: 122021: 152022: 592023: 432024: 502025: 81
2007high 81 (2025) · low 0 (2007)2025

MAUDE reports naming product code OBP, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20082—00
20090—13
20100—00
20110—05
20120—03
20132—01
20141—00
20152—03
2016310106
201787303
2018414416
20193156012
20201—012
20215132015
20226168059
20237119043
20245266050
202512125081
202681761—

What is it indicated for?

ALTMS Magnetic Stimulation Therapy System is indicated for the treatment of Major Depressive Disorder in adult patients, who have failed to achieve satisfactory improvement from prior antidepressant medication in the current episode.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K202537: ALTMS Magnetic Stimulation Therapy System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K202537

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026